Zaltrap (aflibercept)

aflibercept · Regeneron Pharmaceuticals, Inc. / Sanofi

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Zaltrap (aflibercept), covering 2015-01-07 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer [Phase 1]